Absci outlines $25B annual market potential for ABS-201 in AGA and advances endometriosis clinical program (NASDAQ:ABSI)March 25, 2026
Share Facebook Twitter LinkedIn Pinterest Email JD.com in Charts: All operating segments deliver double-digit Y/Y revenue growth in Q1
Absci outlines $25B annual market potential for ABS-201 in AGA and advances endometriosis clinical program (NASDAQ:ABSI)March 25, 2026